High materiality7/10
Krystal Biotech price target raised to $361 from $310 at H.C. Wainwright
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright raises KRYS target to $361; current price $323; upside ~12%.
- Wainwright target $361; current $323; ~12% upside.
Key facts
- 01
Target: $361
- 02
Posted price: $323
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Joseph Pantginis
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.